These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 348455)

  • 1. Absorption, biotransformation, and storage of halothane.
    Holaday DA
    Environ Health Perspect; 1977 Dec; 21():165-9. PubMed ID: 348455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An animal model of hepatotoxicity associated with halothane anesthesia.
    Sipes IG; Brown BR
    Anesthesiology; 1976 Dec; 45(6):622-8. PubMed ID: 984478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pigs.
    Lind RC; Gandolfi AJ; Hall PD
    Anesthesiology; 1990 Dec; 73(6):1208-13. PubMed ID: 2248397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-dependent inhibition of halothane biotransformation in the guinea pig.
    Lind RC; Gandolfi AJ
    Drug Metab Dispos; 1993; 21(2):386-9. PubMed ID: 8097713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the requirements for hepatic injury with halothane and enflurane in rats.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR
    Anesth Analg; 1985 Oct; 64(10):955-63. PubMed ID: 4037395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.
    McLain GE; Sipes IG; Brown BR
    Anesthesiology; 1979 Oct; 51(4):321-6. PubMed ID: 484893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary and biliary excretion of metabolites of halothane in dogs.
    Sakai T; Yoshida H; Fukui A; Takaori M
    Drug Metab Dispos; 1991; 19(2):419-22. PubMed ID: 1676647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane.
    Sipes IG; Gandolfi AJ; Pohl LR; Krishna G; Brown BR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):716-20. PubMed ID: 7400974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
    Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED
    J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents.
    Van Dyke RA; Gandolf AJ
    Drug Metab Dispos; 1976; 4(1):40-4. PubMed ID: 3400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent binding of oxidative biotransformation reactive intermediates to protein influences halothane-associated hepatotoxicity in guinea pigs.
    Lind RC; Gandolfi AJ
    Adv Exp Med Biol; 1991; 283():763-6. PubMed ID: 2069053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cimetidine on anesthetic metabolism and toxicity.
    Wood M; Uetrecht J; Phythyon JM; Shay S; Sweetman BJ; Shaheen O; Wood AJ
    Anesth Analg; 1986 May; 65(5):481-8. PubMed ID: 3963434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity.
    Cousins MJ; Sharp JH; Gourlay GK; Adams JF; Haynes WD; Whitehead R
    Anaesth Intensive Care; 1979 Feb; 7(1):9-24. PubMed ID: 434454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia.
    Lunam CA; Cousins MJ; Hall PD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):802-9. PubMed ID: 3973829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halothane hepatotoxicity and the reduced derivative, 1,1,1-trifluoro-2-chloroethane.
    Brown BR; Sipes IG; Baker RK
    Environ Health Perspect; 1977 Dec; 21():185-8. PubMed ID: 612444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and the kidney.
    Lind RC; Gandolfi AJ
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):201-7. PubMed ID: 9007050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary metabolites of halothane in man.
    Cohen EN; Trudell JR; Edmunds HN; Watson E
    Anesthesiology; 1975 Oct; 43(4):392-401. PubMed ID: 1101753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and halothane metabolism in vivo: release of inorganic fluoride and halothane metabolite binding to cellular constituents.
    Widger LA; Gandolfi AJ; Van Dyke RA
    Anesthesiology; 1976 Mar; 44(3):197-201. PubMed ID: 1267885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the biotransformation of halothane in man.
    Cascorbi HF; Blake DA; Helrich M
    Anesthesiology; 1970 Feb; 32(2):119-23. PubMed ID: 5414289
    [No Abstract]   [Full Text] [Related]  

  • 20. Concordance between trifluoroacetic acid and hepatic protein trifluoroacetylation after disulfiram inhibition of halothane metabolism in rats.
    Spracklin DK; Emery ME; Thummel KE; Kharasch ED
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):765-70. PubMed ID: 12803597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.